Status:
UNKNOWN
A Prospective Cohort Study Of Myasthenia Gravis
Lead Sponsor:
First Affiliated Hospital of Chongqing Medical University
Conditions:
Myasthenia Gravis
Myasthenia Gravis Crisis
Eligibility:
All Genders
Up to 80 years
Brief Summary
The average annual incidence of Myasthenia gravis is up to (8.0-20.0) / 100,000 people. Myasthenia gravis is an acquired autoimmune disease. All skeletal muscles of patients may be involved. When ocul...
Eligibility Criteria
Inclusion
- Meeting the diagnosis of myasthenia gravis
Exclusion
- Malignant tumor or other serious chronic disease
Key Trial Info
Start Date :
December 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04674605
Start Date
December 31 2020
End Date
October 30 2022
Last Update
December 19 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016
2
The First Affiliated Hospital of Chongqing Medical University
Chongqing, YuZhong District, China, 400016